PK

Parth Kantilal Sakariya

Active Director Director DIN 08765262
DIN 08765262 First appointment Jun 2020 Primary industry Food And Beverages
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Parth Kantilal Sakariya

Data last updated:

Parth Kantilal Sakariya is a Director at Nuviton Healthcare Private Limited (since 2020). The company operates in Food And Beverages.

DIN 08765262
Primary Designation Director
Industry Food And Beverages
First Appointment 18 Jun 2020
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nuviton Healthcare Private Limited U24303GJ2017PTC100200
Director18 Jun 20202017Active

Board colleagues of Parth Kantilal Sakariya

Directorship timeline

Open interactive timeline →
Nuviton Healthcare Private Limited
Premium access

Shareholding and investment profile for Parth Kantilal Sakariya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Parth Kantilal Sakariya

Parth Kantilal Sakariya currently holds 1 directorship: Nuviton Healthcare Private Limited (Director, since 18 Jun 2020).

Parth Kantilal Sakariya was first appointed on 18 Jun 2020 as Director at Nuviton Healthcare Private Limited.

The current boards of Parth Kantilal Sakariya's companies include Nilesh Parshottambhai Virani (Nuviton Healthcare Private Limited), Savan Kantilal Sakariya (Nuviton Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available